Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15

Showing 15 citing articles:

Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Francesco Bruno, Paolo Abondio, Rossella Bruno, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102068-102068
Open Access | Times Cited: 41
The role of viruses in cancer progression versus cancer treatment: A dual paradigm
Somya Ranjan Dash, Anushka Kundu, Chanakya Nath Kundu
Life Sciences (2024) Vol. 341, pp. 122506-122506
Closed Access | Times Cited: 6
Utility of the Platelet-to-Lymphocyte Ratio in Predicting Advanced Liver Fibrosis in the Hepatitis C Virus (HCV)-Infected Population
Vijesh Kumar, Muhammad Shoaib Aslam, Shuaib Ahmed Kalwar, et al.
Cureus (2025)
Open Access
Metformin in Antiviral Therapy: Evidence and Perspectives
Iryna Halabitska, Pavlo Petakh, Oleh Lushchak, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1938-1938
Open Access | Times Cited: 2
Interaction Between Hepatitis B, Hepatitis C and Alcohol in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
Jalal Poorolajal, Yahya Shadi, Bahram Heshmati
Journal of Viral Hepatitis (2024) Vol. 32, Iss. 1
Closed Access | Times Cited: 2
Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections
Ali Shojaeian, Mohsen Nakhaie, Zahra Sobhi Amjad, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access | Times Cited: 1
Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard?
Ivana Milošević, Ana Filipović, Branko Beronja, et al.
Microorganisms (2024) Vol. 12, Iss. 10, pp. 2050-2050
Open Access | Times Cited: 1
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Reem El‐Shenawy, Rehab I. Moustafa, Naiera M. Helmy, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection
Marcos Daniel Mendes Padilha, Francisco Tiago de Vasconcelos Melo, Rogério Valois Laurentino, et al.
The Brazilian Journal of Infectious Diseases (2024) Vol. 29, Iss. 1, pp. 104468-104468
Open Access | Times Cited: 1
Interaction between hepatitis B, hepatitis C and smoking in the development of hepatocellular carcinoma: a systematic review and meta-analysis
Yahya Shadi, Bahram Heshmati, Jalal Poorolajal
Journal of Public Health (2023) Vol. 46, Iss. 1, pp. 51-60
Closed Access | Times Cited: 3
Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study
Mehdi Kashani, Mohammad M. Karimi, Alireza Sharifi Rayeni, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Multiclass Classification of Hepatitis C Using Convolutional Neural Networks to Optimize Clinical Decisions
Adven Masih, Ayesha Saddiqa, Mudassar Hussain, et al.
(2024)
Closed Access
Role of HCV in Hepatocellular Carcinoma
Saba Zafar, Farhat Jabeen, Aiman Sajjad
(2024), pp. 113-136
Closed Access
Burden of liver cancer due to hepatitis C from 1990 to 2019 at the global, regional, and national levels
Jie Wei, Guoqing Ouyang, Guozhen Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study
Kei Moriya, Kiyoshi Asada, Shota Suzuki, et al.
Medicine (2022) Vol. 101, Iss. 48, pp. e32127-e32127
Open Access | Times Cited: 1
Page 1

Scroll to top